健康研究
健康研究
건강연구
HEALTH RESEARCH
2014年
5期
510-512
,共3页
乳酸杆菌活性制剂%假丝酵母菌病%妊娠%临床疗效%复发
乳痠桿菌活性製劑%假絲酵母菌病%妊娠%臨床療效%複髮
유산간균활성제제%가사효모균병%임신%림상료효%복발
reactive lactobacillus pharmacy%vulvovaginal candidiasis%pregnancy%clinical curative effect%recurrence rates
目的：探讨克霉唑联合乳酸杆菌活性制剂治疗妊娠期外阴阴道假丝酵母菌病（ vulvovaginal candidiasis ，VVC）的临床疗效。方法将127例妊娠期VVC患者随机分成观察组和对照组，观察组采用克霉唑联合乳酸杆菌活性制剂治疗，对照组单用克霉唑治疗，观察治疗结束后1周的临床疗效和1个月、2个月的复发率。结果治疗结束后1周，观察组的总有效率为95．38％，对照组为93．55％，差异无统计学意义（ P＞0．05）。观察组1个月、2个月复发率分别为2．17％、6．52％；对照组分别为15．38％、25．64％，两组差异有统计学意义（ P＜0.05）。结论克霉唑联合乳酸杆菌活性制剂治疗妊娠期VVC效果与单用克霉唑无明显差异，但在预防复发方面占明显优势。
目的：探討剋黴唑聯閤乳痠桿菌活性製劑治療妊娠期外陰陰道假絲酵母菌病（ vulvovaginal candidiasis ，VVC）的臨床療效。方法將127例妊娠期VVC患者隨機分成觀察組和對照組，觀察組採用剋黴唑聯閤乳痠桿菌活性製劑治療，對照組單用剋黴唑治療，觀察治療結束後1週的臨床療效和1箇月、2箇月的複髮率。結果治療結束後1週，觀察組的總有效率為95．38％，對照組為93．55％，差異無統計學意義（ P＞0．05）。觀察組1箇月、2箇月複髮率分彆為2．17％、6．52％；對照組分彆為15．38％、25．64％，兩組差異有統計學意義（ P＜0.05）。結論剋黴唑聯閤乳痠桿菌活性製劑治療妊娠期VVC效果與單用剋黴唑無明顯差異，但在預防複髮方麵佔明顯優勢。
목적：탐토극매서연합유산간균활성제제치료임신기외음음도가사효모균병（ vulvovaginal candidiasis ，VVC）적림상료효。방법장127례임신기VVC환자수궤분성관찰조화대조조，관찰조채용극매서연합유산간균활성제제치료，대조조단용극매서치료，관찰치료결속후1주적림상료효화1개월、2개월적복발솔。결과치료결속후1주，관찰조적총유효솔위95．38％，대조조위93．55％，차이무통계학의의（ P＞0．05）。관찰조1개월、2개월복발솔분별위2．17％、6．52％；대조조분별위15．38％、25．64％，량조차이유통계학의의（ P＜0.05）。결론극매서연합유산간균활성제제치료임신기VVC효과여단용극매서무명현차이，단재예방복발방면점명현우세。
Objective To understand the clinical effect of reactive lactobacillus pharmacy combined with clotrimazole in curing vulvovaginal candidiasis during pregnancy.Method 127 patients with the disease were randomly divided into an experimental group and a control group.The experimental group were given reactive lactobacillus pharmacy combined with clotrimazole,while the control group were given clotrimazole only.The clinical effects of the medicines on the two groups one week after treatment and recurrence rate within one month and two months were recorded and analyzed.Findings One week after treatment,the total clinical efficacy of the designated medicine on the experimental group was 95.38%.The efficacy of clotrimazole on the control group was 93.55%.The difference was not statistically significance(P>0.05).One month and two months after treatment,the recurrence rates of the experimental group were 2.17%and 6.52%respectively, while the recurrence rates of the control group were 15.38% and 25.64% respectively.The differences between the two groups in recurrence rate were statistically significant (P<0.05).Conclusion The clinical effect of reactive lactobacillus pharmacy combined with clotrimazole in curing vulvovaginal candidiasis during pregnancy was found to bear no prominent difference than that of the clotrimazole.However, it has great advantage in preventing the recurrence of the disease.
